These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20453631)

  • 1. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study.
    ; Smith C; Sabin CA; Lundgren JD; Thiebaut R; Weber R; Law M; Monforte Ad; Kirk O; Friis-Moller N; Phillips A; Reiss P; El Sadr W; Pradier C; Worm SW
    AIDS; 2010 Jun; 24(10):1537-48. PubMed ID: 20453631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
    Monforte Ad; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law M; De Wit S; Friis-Møller N; Phillips AN; Sabin CA; Lundgren JD;
    AIDS; 2008 Oct; 22(16):2143-53. PubMed ID: 18832878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies.
    Trickey A; McGinnis K; Gill MJ; Abgrall S; Berenguer J; Wyen C; Hessamfar M; Reiss P; Kusejko K; Silverberg MJ; Imaz A; Teira R; d'Arminio Monforte A; Zangerle R; Guest JL; Papastamopoulos V; Crane H; Sterling TR; Grabar S; Ingle SM; Sterne JAC
    Lancet HIV; 2024 Mar; 11(3):e176-e185. PubMed ID: 38280393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort.
    Garriga C; García de Olalla P; Miró JM; Ocaña I; Knobel H; Barberá MJ; Humet V; Domingo P; Gatell JM; Ribera E; Gurguí M; Marco A; Caylà JA;
    PLoS One; 2015; 10(12):e0145701. PubMed ID: 26716982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study.
    Weber MSR; Duran Ramirez JJ; Hentzien M; Cavassini M; Bernasconi E; Hofmann E; Furrer H; Kovari H; Stöckle M; Schmid P; Haerry D; Braun DL; Günthard HF; Kusejko K;
    Clin Infect Dis; 2024 Jul; 79(1):177-188. PubMed ID: 38214897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*).
    Petoumenos K; Worm S; Reiss P; de Wit S; d'Arminio Monforte A; Sabin C; Friis-Møller N; Weber R; Mercie P; Pradier C; El-Sadr W; Kirk O; Lundgren J; Law M;
    HIV Med; 2011 Aug; 12(7):412-21. PubMed ID: 21251183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the burden of HIV late presentation and its attributable morbidity and mortality across Europe 2010-2016.
    Late Presentation Working Groups in EuroSIDA and COHERE
    BMC Infect Dis; 2020 Oct; 20(1):728. PubMed ID: 33028235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Cause-Specific Mortality Among Veterans With HIV: A 35-Year (1982-2016) Analysis of the HIV Atlanta VA Cohort Study.
    Vyas KJ; Marconi VC; Moanna A; Rimland D; Guest JL
    J Acquir Immune Defic Syndr; 2023 Jan; 92(1):17-26. PubMed ID: 36166297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National review of deaths among HIV-infected adults.
    Lucas SB; Curtis H; Johnson MA
    Clin Med (Lond); 2008 Jun; 8(3):250-2. PubMed ID: 18624028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.
    Tusch E; Ryom L; Pelchen-Matthews A; Mocroft A; Elbirt D; Oprea C; Günthard HF; Staehelin C; Zangerle R; Suarez I; Vehreschild JJ; Wit F; Menozzi M; d'Arminio Monforte A; Spagnuolo V; Pradier C; Carlander C; Suanzes P; Wasmuth JC; Carr A; Petoumenos K; Borgans F; Bonnet F; De Wit S; El-Sadr W; Neesgaard B; Jaschinski N; Greenberg L; Hosein SR; Gallant J; Vannappagari V; Young L; Sabin C; Lundgren J; Peters L; Reekie J; ;
    Clin Infect Dis; 2024 Apr; ():. PubMed ID: 38663013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and causes of death among people with HIV in Brighton and Hove 2017-2020.
    Pattinson FR; Cavilla S; Croxford S; Post FA; Miller R; Sullivan A; Churchill DR; Dean GL
    Sex Transm Infect; 2023 Nov; 99(7):503. PubMed ID: 37562950
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.
    Smith CJ; Ryom L; Weber R; Morlat P; Pradier C; Reiss P; Kowalska JD; de Wit S; Law M; el Sadr W; Kirk O; Friis-Moller N; Monforte Ad; Phillips AN; Sabin CA; Lundgren JD;
    Lancet; 2014 Jul; 384(9939):241-8. PubMed ID: 25042234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.
    Friis-Møller N; Thiébaut R; Reiss P; Weber R; Monforte AD; De Wit S; El-Sadr W; Fontas E; Worm S; Kirk O; Phillips A; Sabin CA; Lundgren JD; Law MG;
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):491-501. PubMed ID: 20543702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
    Petoumenos K; Worm SW; Fontas E; Weber R; De Wit S; Bruyand M; Reiss P; El-Sadr W; Monforte AD; Friis-Møller N; Lundgren JD; Law MG;
    J Int AIDS Soc; 2012 Oct; 15(2):17426. PubMed ID: 23078769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?
    Underwood J; Robertson KR; Winston A
    AIDS; 2015 Jan; 29(3):253-61. PubMed ID: 25426811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.
    Konerman MA; Mehta SH; Sutcliffe CG; Vu T; Higgins Y; Torbenson MS; Moore RD; Thomas DL; Sulkowski MS
    Hepatology; 2014 Mar; 59(3):767-75. PubMed ID: 24436062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous clearance and treatment of acute hepatitis C infection in HIV-positive men with 48 weeks of interferon-alpha and ribavirin.
    Webster DP; Wojcikiewicz T; Keller M; Castelnovo D; Mistry H; Gilleece Y; Tibble J; Fisher M
    Int J STD AIDS; 2013 Mar; 24(3):179-83. PubMed ID: 23514835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and the risk of acute myocardial infarction.
    Freiberg MS; Chang CC; Kuller LH; Skanderson M; Lowy E; Kraemer KL; Butt AA; Bidwell Goetz M; Leaf D; Oursler KA; Rimland D; Rodriguez Barradas M; Brown S; Gibert C; McGinnis K; Crothers K; Sico J; Crane H; Warner A; Gottlieb S; Gottdiener J; Tracy RP; Budoff M; Watson C; Armah KA; Doebler D; Bryant K; Justice AC
    JAMA Intern Med; 2013 Apr; 173(8):614-22. PubMed ID: 23459863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.
    Limketkai BN; Mehta SH; Sutcliffe CG; Higgins YM; Torbenson MS; Brinkley SC; Moore RD; Thomas DL; Sulkowski MS
    JAMA; 2012 Jul; 308(4):370-8. PubMed ID: 22820790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder.
    Letendre S
    Top Antivir Med; 2011 Nov; 19(4):137-42. PubMed ID: 22156215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.